NKX2-1 Restricts the Growth and Metastasis of Lung Squamous Cell Carcinoma Through Transcriptive Suppression of

Dan Yu1, Ping Liu1, Ruichen Gao1

  • 1Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Nanjing Medical University, The Second People's Hospital of Changzhou, Changzhou, China.

Insights

NKX2-1 acts as a tumor suppressor in lung squamous cell carcinoma (LUSC). Lower NKX2-1 levels correlate with poor survival, and its overexpression inhibits LUSC cell growth and metastasis by repressing AKR1B10.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Lung squamous cell carcinoma (LUSC) presents a significant clinical challenge due to poor prognosis and limited therapeutic strategies.
  • The role of NKX2-1, a transcription factor, in LUSC pathogenesis remains incompletely understood.
  • Identifying novel tumor suppressors and their mechanisms is crucial for developing effective LUSC treatments.

Purpose of the Study:

  • To investigate the function of NKX2-1 as a potential tumor suppressor in LUSC.
  • To elucidate the molecular mechanisms underlying NKX2-1's role in LUSC progression.
  • To explore NKX2-1 and its downstream targets as potential therapeutic avenues for LUSC.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) data for NKX2-1 expression and correlation with patient survival.
  • In vitro functional assays including CCK8, colony formation, EdU incorporation, wound healing, and Transwell assays to assess proliferation, migration, and invasion.
  • In vivo studies using a subcutaneous xenograft model to evaluate tumorigenic potential.
  • Transcriptomic analysis and dual-luciferase reporter assays to identify and validate NKX2-1 targets.

Main Results:

  • NKX2-1 expression is significantly downregulated in LUSC tissues compared to lung adenocarcinoma (LUAD) and normal lung tissues, with lower expression linked to poorer survival.
  • Overexpression of NKX2-1 suppressed proliferation, migration, and invasion in LUSC cell lines (SK-MES-1, NCI-H520) and reduced tumor growth in vivo.
  • NKX2-1 directly suppresses AKR1B10 transcription, and this repression is critical for NKX2-1's tumor-suppressive effects in LUSC.

Conclusions:

  • NKX2-1 functions as a tumor suppressor in LUSC by inhibiting cell proliferation, migration, and invasion.
  • The tumor-suppressive activity of NKX2-1 is mediated, at least in part, through the repression of AKR1B10 transcription.
  • Targeting the NKX2-1/AKR1B10 pathway may offer a novel therapeutic strategy for improving outcomes in LUSC patients.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K